p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
Open accessAbstract
Maintenance of telomere length and function is critical for the efficient proliferation of eukaryotic cells. Here, we examine the interactions between telomere dysfunction and p53 in cells and organs of telomerase-deficient mice. Coincident with severe telomere shortening and associated genomic instability, p53 is activated, leading to growth arrest and/or apoptosis. Deletion of p53 significantly attenuated the adverse cellular and organismal effects of telomere dysfunction, but only during the earliest stages of genetic crisis. Correspondingly, the loss of telomere function and p53 deficiency cooperated to initiate the transformation process. Together, these studies establish a key role for p53 in the cellular response to telomere dysfunction in both normal and neoplastic cells, question the significance of crisis as a tumor suppressor mechanism, and identify a biologically relevant stage of advanced crisis, termed genetic catastrophe.
Verified 2026-10-06 · 12 references not checked yet
AI snapshot
Written from the paper’s full text.
TL;DR
In telomerase-deficient (mTR−/−) mice, critically short telomeres activate p53, and deleting p53 rescues the resulting apoptosis and cell-cycle arrest — but only during early "crisis." Loss of telomere function and p53 deficiency cooperate to initiate transformation, while telomerase reconstitution mainly benefits later stages of tumorigenesis.
Key findings
- Critical telomere shortening activates p53: p53 protein was detectable in G6 mTR−/− testis but not in mTR+/+ or G6 mTR−/− p53−/− littermates; >80% of G4 and G6 MEFs stained positive for p53 at passage 6 versus 21% of mTR+/+ MEFs. p21CIP1/WAF1 rose 3- to 4-fold in G6 versus G2 mTR−/− p53+/+ MEFs, and p53-dependent CAT reporter activity increased ~2-fold.
- p53 loss rescued telomere-dysfunction phenotypes early but not late: 15% of G4–G6 mTR−/− mice (86/565) were p53−/− versus 26% of G7–G8 mice (24/91) (p = 0.015); all G5 mTR−/− p53−/− testes had normal histology, but 3 of 7 G6 and all five G7–G8 samples showed germ cell depletion. G6 mTR−/− p53−/− MEFs showed a 3-fold increase in chromosome fusions (1.65, SD 2.59 vs 0.42, SD 0.71 per metaphase; p = 0.012), with no change in telomere length (75% reduction regardless of p53 status).
- Telomere dysfunction cooperated with p53 deficiency to initiate transformation: adding mTR suppressed Myc/RAS focus formation in G6 mTR−/− p53−/− MEFs, but mTR-transfected foci had higher subcloning efficiency (23/26, 89%) than vector foci (19/32, 59%; p = 0.018). Tumor formation in SCID mice was similar between groups.
- The authors propose dividing crisis into p53-dependent "early crisis" and p53-independent "genetic catastrophe," questioning crisis as a tumor suppressor mechanism.
Methods
- Mouse genetics: mTR+/− mice crossed with p53+/− mice to generate successive generations (G1–G8) of mTR−/− animals with p53+/+, +/−, and −/− genotypes in a mixed WW6/C57BL/6 background; p53 status maintained heterozygous during matings.
- Cellular/organ assays: immunoblotting and immunohistochemistry for p53 and p21, pG13CAT reporter assays, testis histology with TUNEL, BrdU/propidium iodide FACS cell-cycle profiles, flow FISH telomere length, and metaphase spreads for chromosome fusions.
- Transformation assays: Myc/RAS cotransfection of early-passage MEFs with empty vector or an mTR genomic fragment, scoring focus formation, subcloning efficiency, and tumor formation after subcutaneous injection into SCID mice.
Limitations
- Stated: the mechanisms by which tumorigenic potential is maintained in late stages of tumorigenesis despite telomere dysfunction "remain to be determined"; whether loss of TRF2 binding, short telomeres, or fusion-bridge-breakage cycles mediate the p53 induction described also remains undetermined.
- Evident from the text: the G7–G8 genotype comparison rests on small numbers (24 of 91 mice), and all mice are in a mixed genetic background, which the authors note required cousin mating to avoid substrains.
- Evident from the text: the transformation data are from cultured MEFs and SCID xenografts, and tumor weights/efficiency between mTR and vector lines were not significantly different, so the in vivo relevance of the initiation advantage is inferred rather than directly demonstrated.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 37 cited sources checked · 0 supported · 0 flagged
- Findingreasoning§ Abstract
Loss of telomere function and p53 deficiency cooperated to initiate the transformation process.
“Correspondingly, the loss of telomere function and p53 deficiency cooperated to initiate the transformation process.”
Quote in the paperSubstantial claim - Findingnone given§ Abstract
Coincident with severe telomere shortening and associated genomic instability, p53 is activated, leading to growth arrest and/or apoptosis.
“Coincident with severe telomere shortening and associated genomic instability, p53 is activated, leading to growth arrest and/or apoptosis.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
CAT activity was strictly dependent upon p53.
“This activity was strictly dependent upon p53, since p53−/− and G6 mTR−/− p53−/− MEF cultures showed only background levels of CAT activity.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
p53 mediates the adverse effects of critically shortened telomeres.
“We found that p53 mediates the adverse effects of critically shortened telomeres.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
DNA content analyses of G6 mTR−/− p53+/+ MEFs revealed a profile consistent with a biphasic block as evidenced by marked accumulation of cells in G1 and G2/M phases.
“As shown in Figure 3A, DNA content analyses of G6 mTR−/− p53+/+ MEFs revealed a profile consistent with a biphasic block as evidenced by marked accumulation of cells in G1 and G2/M phases.”
Quote in the paperSubstantial claim
- Findingown data§ Abstract
Analysis of metaphase spreads derived from G6 mTR−/− p53+/+ MEFs showed a rate of 0.42 (SD 0.71) chromosomal fusions per metaphase.
“Indeed, analysis of metaphase spreads derived from G6 mTR−/− p53+/+ MEFs showed a rate of 0.42 (SD 0.71) chromosomal fusions per metaphase, a rate consistent with previous studies (Figure 3D) (Blasco et al. 1997; Greenberg et al. 1999; Rudolph et al. 1999”
Quote in the paperNot a substantial claim0 of 3 sources checked - Findingown data§ Abstract
p53-independent cell death becomes a more consistent feature in G7 and G8, since all of the five G7-G8 mTR−/− p53−/− testis samples showed significant germ cell depletion microscopically.
“Furthermore, p53-independent cell death becomes a more consistent feature in G7 and G8, since all of the five G7–G8 mTR−/− p53−/− testis samples showed significant germ cell depletion microscopically (Figure 2D).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
A relative increase in p53−/− mice was evident in G7 and G8 mTR−/− background (24% and 38%, respectively).
“However, a relative increase in p53−/− mice was evident in G7 and G8 mTR−/− background (24% and 38%, respectively).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Gross testis size was consistently rescued to near normal in G6 mTR−/− p53−/− mice compared to G6 mTR−/− p53+/+ littermates.
“Gross testis size was consistently rescued to near normal in G6 mTR−/− p53−/− mice compared to G6 mTR−/− p53+/+ littermates (see Figure 2A for representative comparison).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Loss of telomere function and p53 deficiency can cooperate to enhance transformation.
“Furthermore, loss of telomere function and p53 deficiency can cooperate to enhance transformation.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Transfection of the mTR genomic fragment restored telomerase activity in mTR−/− cells.
“Transfection of this mTR genomic fragment restored telomerase activity in mTR−/− cells (Figure 4B).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Modest attenuation of the cell cycle block was evident in G6 mTR−/− p53+/− cultures, suggesting functional haploinsufficiency.
“Modest attenuation of the cell cycle block was evident in the G6 mTR−/− p53+/− cultures, suggesting functional haploinsufficiency.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Loss of p53 does not appear to eliminate the cell cycle blocks completely, since G6 mTR−/− p53−/− MEFs still exhibited fewer cells in S phase (33% vs. 55%) and more cells in G2/M (14% vs. 7%) than mTR+/+ p53−/− MEFs.
“However, loss of p53 does not appear to eliminate the cell cycle blocks completely, since G6 mTR−/− p53−/− MEFs still exhibited fewer cells in S phase (33% vs. 55%) and more cells in G2/M (14% vs. 7%) than mTR+/+ p53−/− MEFs.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Similar results were obtained for primary thymocytes, irrespective of p53 status.
“Similar results were obtained for primary thymocytes, irrespective of p53 status (Figure 3C).”
Quote in the paperNot a substantial claim - Findingown data§ Abstract
Endogenous p21CIP1/WAF1 levels were increased 3- to 4-fold in late-generation G6 mTR−/− p53+/+ MEFs compared to early-generation G2 mTR−/− p53+/+ MEFs.
“Endogenous p21CIP1/WAF1 levels were increased 3- to 4-fold in late-generation G6 mTR−/− p53+/+ MEFs compared to early-generation G2 mTR−/− p53+/+ MEFs (Figure 1C).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Most of the G5-G7 mTR−/− p53−/− mice showed improved histology compared to their age-matched controls with competent p53 function.
“Most of the G5–G7 mTR−/− p53−/− mice showed improved histology compared to their age-matched controls with competent p53 function.”
Quote in the paperSubstantial claim - Findingcitation§ Abstract
In mTR−/− mice, a decrease in testis size that correlated with germ cell depletion by histology was first evident in G5 mTR−/− animals and became more prevalent in G6 mTR−/− mice.
“In mTR−/− mice, a decrease in testis size that correlated with germ cell depletion by histology was first evident in G5 mTR−/− animals and became more prevalent in G6 mTR−/− mice (Lee et al. 1998”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lee et al. 1998 source
Not checked in the free run.
- Findingown data§ Abstract
When established cell lines were injected into SCID mice, mTR lines and vector lines formed tumors with similar efficiency.
“However, when these established cell lines were injected into SCID mice, mTR lines and vector lines formed tumors with similar efficiency (Figure 4D).”
Quote in the paperSubstantial claim - Findingcitation§ Abstract
In G6 mTR−/− p53+/− intercrosses, an unusually high rate of productive mating pairs (11 of 22) was observed compared to G6 mTR−/− p53+/+ matings.
“In the G6 mTR−/− p53+/− intercrosses, we observed an unusually high rate of productive mating pairs (11 of 22 mating pairs) compared to G6 mTR−/− p53+/+ matings (Lee et al. 1998”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee et al. 1998 source
Not checked in the free run.
- Findingown data§ Abstract
Addition of mTR consistently suppressed the rate of Myc/RAS focus formation in G6 mTR−/− p53−/− MEFs.
“we demonstrated that the addition of mTR consistently suppressed the rate of Myc/RAS focus formation in G6 mTR−/− p53−/− MEFs (Table 2)”
Quote in the paperSubstantial claim - Findingown data§ Abstract
MEFs from mTR+/+ mice and from late-generation mTR−/− mice exhibited marked differences in the proportion of cells expressing p53.
“MEFs from mTR+/+ mice and from late-generation mTR−/− mice exhibited marked differences in the proportion of cells expressing p53 as determined by immunohistochemistry.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
The G8 mTR−/− p53−/− mouse that exhibited relatively normal histology had significantly longer telomere length than the other G8 mTR−/− p53−/− mouse.
“Of note, the G8 mTR−/− p53−/− mouse that exhibited a relatively normal histology (1+ germ cell depletion, Table 1) had significantly longer telomere length by flow FISH determination (data not shown) than the other G8 mTR−/− p53−/− mouse.”
Quote in the paperNot a substantial claim - Findingown data§ Abstract
CAT activity was increased approximately 2-fold in G6 mTR−/− MEFs compared to mTR+/+ p53+/+ controls at identical passage number.
“After normalization for transfection efficiency, CAT activity was increased approximately 2-fold in G6 mTR−/− MEFs compared to mTR+/+ p53+/+ controls at identical passage number (Figure 1D).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
TUNEL assays demonstrated that the restoration of germ cells in the G5-G7 mTR−/− p53−/− testis is accompanied by a dramatic reduction of apoptosis to levels observed in mTR+/+ testis.
“TUNEL assays demonstrated that the restoration of germ cells in the G5–G7 mTR−/− p53−/− testis is accompanied by a dramatic reduction of apoptosis to levels observed in mTR+/+ testis (Figure 2C).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
p21CIP1/WAF1 induction in mTR−/− cells is largely p53 dependent.
“As anticipated, p21CIP1/WAF1 was not detected in G6 mTR−/− p53−/− cells, indicating that p21CIP1/WAF1 induction in mTR−/− cells is largely p53 dependent.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
The average weight of mTR tumors was not significantly different from that of vector tumors.
“Furthermore, the average weight of mTR tumors was not significantly different from that of the vector tumors.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Restoration of telomerase activity in mTR+/+ p53−/− MEFs had no significant effect on focus formation.
“while restoration of telomerase activity in mTR+/+ p53−/− MEFs had no significant effect (data not shown).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
All G6 mTR−/− MEF cultures regardless of p53 status exhibited an equivalent and marked decline in mean telomere signal relative to mTR+/+ MEFs (75% reduction).
“As shown in Figure 3B, all of the G6 mTR−/− MEF cultures regardless of p53 status exhibited an equivalent and marked decline in mean telomere signal relative to mTR+/+ MEFs (75% reduction).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
p53−/− mice were underrepresented as a percentage of total mice in late-generation mTR−/− background (19%, 15%, and 14% for G4, G5, and G6 respectively).
“p53−/− mice were underrepresented as a percentage of total mice in late-generation mTR−/− background (19%, 15%, and 14% for G4, G5, and G6 respectively) (Figure 1E).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Myc/RAS foci transfected with mTR exhibited a significant enhancement in subcloning efficiency: 23 of 26 (89%) mTR foci were established as permanent cell lines compared with 19 of 32 (59%) vector foci (p = 0.018).
“Myc/RAS foci transfected with mTR exhibited a significant enhancement in subcloning efficiency—23 of 26 (89%) mTR foci were successfully established as permanent cell lines compared with only 19 of 32 (59%) vector foci (Figures 4C, p value = 0.018).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
As telomere function worsens in later generations of mTR deficiency, germ cell death by p53-independent mechanisms becomes evident.
“As telomere function worsens in later generations of mTR deficiency, germ cell death by p53-independent mechanisms becomes evident.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Productive matings arising from G7 mTR−/− p53+/− pairs (5 of 17) yielded G8 mTR−/− offspring of all three p53 genotypes.
“Significantly, we also observed productive matings arising from G7 mTR−/− p53+/− pairs (5 of 17 mating pairs) to yield G8 mTR−/− offspring of all three p53 genotypes.”
Quote in the paperSubstantial claim - Premisecitation§ Introduction
Telomere shortening in the absence of telomerase plays a critical role in signaling entry into senescence.
“Thus, telomere shortening in the absence of telomerase plays a critical role in signaling entry into senescence”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationreasoning§ Abstract
The oncogenic potential of a would-be cancer cell bearing short telomeres may depend upon its genetic profile.
“These results indicate that the oncogenic potential of a would-be cancer cell bearing short telomeres may depend upon its genetic profile.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
SV40 large T antigen efficiently transformed cells from late-generation mTR−/− mice despite evidence for telomere dysfunction.
“In contrast, SV40 large T antigen efficiently transformed cells from late-generation mTR−/− mice despite evidence for telomere dysfunction (Blasco et al. 1997; Greenberg et al. 1999”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning§ Abstract
p53 plays a key role in the cellular response to telomere dysfunction in both normal and neoplastic cells.
“Together, these studies establish a key role for p53 in the cellular response to telomere dysfunction in both normal and neoplastic cells”
Quote in the paperSubstantial claim - Interpretationreasoning§ Abstract
There is a biologically relevant stage of advanced crisis, termed genetic catastrophe.
“identify a biologically relevant stage of advanced crisis, termed genetic catastrophe.”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
The inactivation of Rb and/or p53 may account for the efficient transformation of cells with significant telomere loss by SV40 large T antigen.
“The inactivation of Rb and/or p53 may account for the efficient transformation of cells with significant telomere loss by SV40 large T antigen.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
In cancer-prone mice rendered doubly null for the INK4a tumor suppressor and mTR, shortened telomeres markedly reduced both cancer incidence and transformation by cellular oncogenes.
“In cancer-prone mice rendered doubly null for the INK4a tumor suppressor and mTR, shortened telomeres markedly reduced both cancer incidence and transformation by cellular oncogenes (Greenberg et al., 1999”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Greenberg et al., 1999 source
Not checked in the free run.
- Interpretationown data§ Abstract
Telomerase provides a significant advantage in steps following the initiation of cellular transformation.
“Taken together, the differences in the subcloning efficiency of the mTR versus vector cells and their similarity in tumorigenic potential following prolonged passage in culture argue that telomerase provides a significant advantage in steps following the initiation of cellular transformation.”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
Once telomerase-deficient cells have adapted to existing telomere dysfunction, they grow as efficiently as telomerase-expressing cells.
“However, once telomerase-deficient cells have adapted to the existing telomere dysfunction, they grow as efficiently as telomerase-expressing cells.”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
The specific response to telomere dysfunction can be either growth arrest or apoptosis depending upon cell type, p53 pathway status, and physiological context.
“Similar to well-characterized DNA damage checkpoints, the specific response to telomere dysfunction can be either growth arrest or apoptosis depending upon cell type, p53 pathway status, and physiological context.”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
Germ cell apoptosis coincident with telomere loss is mediated by p53.
“These findings indicate that germ cell apoptosis coincident with telomere loss is mediated by p53.”
Quote in the paperSubstantial claim - Premisecitation§ Results
Loss of telomere function in late-generation (G4 onward) mTR−/− mice adversely affects the morphology and physiology of diverse cell types and organ systems.
“Loss of telomere function in late-generation (G4 onward) mTR−/− mice has been shown to adversely affect the morphology and physiology of diverse cell types and organ systems (Lee et al. 1998; Rudolph et al. 1999”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data§ Abstract
Cell death in the context of extreme telomere dysfunction, genetic instability, and p53 deficiency in G7 and G8 mTR−/− mice may represent a more accurate model of the late stage of crisis experienced by human cells that bypass senescence.
“Therefore, cell death in the context of extreme telomere dysfunction, genetic instability, and p53 deficiency in G7 and G8 mTR−/− mice may represent a more accurate model of the late stage of crisis experienced by human cells that bypass senescence (see Discussion).”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
p53 plays a key role in the cellular response to telomere dysfunction in vivo in both normal and neoplastic cells, particularly during early stages of genomic crisis.
“Nevertheless, we have established that p53 plays a key role in the cellular response to telomere dysfunction in vivo in both normal and neoplastic cells, a role that is particularly prominent during the early stages of genomic crisis.”
Quote in the paperSubstantial claim- Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
- Interpretationreasoning§ Discussion
Late crisis is not a checkpoint but represents the consequence of unimpeded proliferation in the absence of functional telomeres and p53.
“We propose that late crisis is not a checkpoint but instead represents the consequence of unimpeded proliferation in the absence of two powerful genome-stabilizing factors: functional telomeres and p53.”
Quote in the paperSubstantial claim- Rests on an assumption: Human cells require inactivation of Rb and/or p53 to bypass the major checkpoint that limits replicative lifespan: cellular senescence.
- Rests on an assumption: Rb/p53 inactivation allows continued cell division beyond senescence, progressive telomere shortening, and entry into crisis, from which only rare survivors emerge.
- Interpretationreasoning§ Discussion
p53 is an important effector in a pathway activated by loss of telomere function.
“Together these data establish p53 as an important effector in a pathway activated by loss of telomere function.”
Quote in the paperSubstantial claim- Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
- Interpretationreasoning§ Abstract
The rescue of proliferation, cellularity, and cell death in telomerase-deficient mice is due to loss of p53 checkpoint functions.
“The rescue of proliferation, cellularity, and cell death is therefore due to loss of p53 checkpoint functions.”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
Critical telomere shortening and associated chromosomal instability correlate with an increase in the level and activation of the p53 protein.
“Together, these data indicate that critical telomere shortening and the associated chromosomal instability correlate with an increase in the level and the activation of the p53 protein.”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
Cell death in early crisis is p53 dependent.
“Cell death in early crisis is p53 dependent.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Discussion
The p53-mediated pathway can dramatically affect the consequence of telomere shortening during carcinogenesis.
“Furthermore, this p53-mediated pathway can dramatically affect the consequence of telomere shortening during carcinogenesis.”
Quote in the paperSubstantial claim- Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
- Interpretationown data§ Abstract
As telomere function worsens in G7 and G8, p53+/+ and p53+/− mice are at a significant survival disadvantage compared to p53−/− mice.
“These data indicate that as telomere function worsens in G7 and G8, p53+/+ and p53+/− mice are at a significant survival disadvantage compared to p53−/− mice.”
Quote in the paperSubstantial claim - Premiseown data§ Discussion
Addition of mTR to Myc/RAS cotransfections of late-generation mTR−/− INK4a−/− MEFs enhanced the rate of focus formation relative to empty vector controls.
“Most significantly, in contrast to late-generation mTR−/− p53−/− MEFs, addition of mTR to the Myc/RAS cotransfections of late-generation mTR−/− INK4a−/− MEFs enhanced the rate of focus formation relative to empty vector controls.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Greenberg et al. 1999 source
Not checked in the free run.
- Interpretationreasoning§ Discussion
Activation of telomerase enhances cell survival possibly through avoidance of the p53-independent death of genetic catastrophe.
“Thus, the activation of telomerase enhances cell survival possibly through avoidance of the p53-independent death of genetic catastrophe (Figure 5).”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
The period defined as crisis in cultured cells can be divided into two phases: early crisis and late crisis (genetic catastrophe).
“Our in vivo and cell culture data suggest that the period defined as crisis in cultured cells can be divided into two phases: “early crisis” and “late crisis,” the latter we term “genetic catastrophe” (Figure 5).”
Quote in the paperSubstantial claim- Rests on an assumption: Human cells require inactivation of Rb and/or p53 to bypass the major checkpoint that limits replicative lifespan: cellular senescence.
- Rests on an assumption: Rb/p53 inactivation allows continued cell division beyond senescence, progressive telomere shortening, and entry into crisis, from which only rare survivors emerge.
- Interpretationreasoning§ Discussion
In other cells, increased aneuploidy or fusion-bridge-breakage may facilitate genetic changes that promote survival, such as oncogene activation, tumor suppressor deletion, reactivation of telomere maintenance mechanisms, or adaptation to telomere dysfunction.
“In other cells, increased aneuploidy or fusion-bridge-breakage may facilitate genetic changes that promote survival, such as oncogene activation, tumor suppressor deletion, reactivation of telomere maintenance mechanisms, or adaptation to telomere dysfunction (e.g., Myc/RAS-expressing G6 mTR−/− p53−/− MEFs) (Figure 5).”
Quote in the paperSubstantial claim - Interpretationreasoning§ Abstract
The p53 pathway may alter the cellular response to telomere loss in both normal and neoplastic cells.
“The contrasting effect of telomere loss on cellular transformation phenotypes in cells that have intact or inactivated DNA damage pathways suggested that the p53 pathway may alter the cellular response to telomere loss in both normal and neoplastic cells.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Discussion
Cells that cannot reestablish telomere maintenance or tolerate genomic instability (e.g., germ cells in G7 and G8) will die.
“Cells that cannot reestablish telomere maintenance or tolerate genomic instability (e.g., germ cells in G7 and G8) will die.”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
Telomere dysfunction cooperates with p53 deficiency to facilitate cellular transformation.
“This unanticipated result indicates that telomere dysfunction cooperates with p53 deficiency to facilitate cellular transformation.”
Quote in the paperSubstantial claim- Rests on an assumption: Focus formation reflects the earliest stages of oncogenic transformation.
- Interpretationreasoning§ Discussion
The mTR−/− INK4a−/− study provides strong in vivo support for the hypothesis that maintenance of telomere function is required for efficient tumorigenesis.
“The mTR−/− INK4a−/− study provides strong in vivo support for the hypothesis that maintenance of telomere function is required for efficient tumorigenesis.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Discussion
In cancer cells harboring intact DNA damage response pathways such as INK4a−/− p53+/+ genotype, pharmacological inhibition of telomerase and subsequent telomere shortening would be predicted to be more therapeutically efficacious.
“However, in cancer cells harboring intact DNA damage response pathways such as those with an INK4a−/− p53+/+ genotype, pharmacological inhibition of telomerase and subsequent telomere shortening would be predicted to be more therapeutically efficacious.”
Quote in the paperSubstantial claim
- May combine two claims. 36
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 16
May combine two claims.
Findingown data§ AbstractDeletion of p53 significantly attenuated the adverse cellular and organismal effects of telomere dysfunction, but only during the earliest stages of genetic crisis.
“Deletion of p53 significantly attenuated the adverse cellular and organismal effects of telomere dysfunction, but only during the earliest stages of genetic crisis.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ AbstractmTR+/+ p53+/+ MEF cultures demonstrated 35% of cells in S phase and only 13% in G2/M.
“In contrast, mTR+/+ p53+/+ MEF cultures demonstrated 35% of cells in S phase and only 13% in G2/M.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ AbstractIn mTR+/+ testis, p53 status did not affect testicular volume or significantly alter the cytoarchitecture of seminiferous tubules.
“In mTR+/+ testis, p53 status did not affect testicular volume or significantly alter the cytoarchitecture of seminiferous tubules (Figure 2A and Figure 2B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ AbstractOnly 21% of mTR+/+ MEFs at passage 6 stained positive for p53, whereas more than 80% of MEFs derived from G4 and G6 exhibited strong immunoreactivity to p53.
“Whereas only 21% of the mTR+/+ MEFs at passage 6 stained positive for p53, more than 80% of MEFs derived from G4 and G6 exhibited strong immunoreactivity to p53 (Figure 1B, compare [a] with [b] and [c]).”
Quote in the paperSubstantial claimMay combine two claims.
Findingreasoning§ DiscussionIn male germ cells and lymphocytes, telomere loss elicits a strong apoptotic response, whereas MEFs experience a potent biphasic cell cycle block.
“In male germ cells and lymphocytes, telomere loss elicits a strong apoptotic response, whereas MEFs experience a potent biphasic cell cycle block.”
Quote in the paperSubstantial claim- Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
May combine two claims.
Findingown data§ AbstractAll G5 mTR−/− p53−/− testes exhibited normal histology, while 3 of 7 G6 mTR−/− p53−/− samples still showed varying degrees of pathology.
“Whereas all G5 mTR−/− p53−/− testes exhibited normal histology, 3 of 7 G6 mTR−/− p53−/− samples still showed varying degrees of pathology (Table 1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ AbstractBrdU incorporation assay showed that 36% of G6 mTR−/− p53+/+ cells were in G1 phase, 3% were in S phase, and 40% were in G2/M.
“Accordingly, BrdU incorporation assay showed that 36% of the G6 mTR−/− p53+/+ cells were in G1 phase, 3% were in S phase, and 40% were in G2/M (Figure 3A, top panel).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ ResultsImmunoprecipitation and Western blot analysis detected p53 in lysates from G6 mTR−/− testis, but not in lysates from age-matched mTR+/+ testis or from G6 mTR−/− p53−/− littermate controls.
“Immunoprecipitation and Western blot analysis readily detected p53 in lysates from G6 mTR−/− testis, but not in lysates derived from age-matched mTR+/+ testis or from G6 mTR−/− p53−/− littermate controls (Figure 1A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingcitation§ ResultsThe induction of p53 coincides with a dramatic increase in apoptosis and decreased cellularity in the G6 mTR−/− testis.
“This induction of p53 coincides with the dramatic increase in apoptosis (as assessed by TUNEL) and decreased cellularity in the G6 mTR−/− testis (Lee et al. 1998”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee et al. 1998 source
Not checked in the free run.
May combine two claims.
Findingreasoning§ DiscussionLoss of p53 rescues the cell cycle arrest in MEFs and the apoptotic elimination of male germ cells.
“Significantly, loss of p53 rescues the cell cycle arrest in MEFs and the apoptotic elimination of male germ cells.”
Quote in the paperSubstantial claim- Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
The quote only partly states this claim.
Findingown data§ AbstractLoss of p53 abrogated the cell cycle block in G6 mTR−/− MEFs.
“loss of p53 abrogated this block.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Abstract15% of G4-G6 mTR−/− mice (86 out of 565) were p53−/− compared to 26% of G7-G8 mTR−/− mice (24 of 91) (p = 0.015).
“Significantly, 15% of the G4–G6 mTR−/− mice (86 out of 565 mice) were p53−/− compared to 26% of the G7–G8 mTR−/− mice (24 of 91 mice) (p = 0.015 by Fisher’s two-sided t test) (Figure 1E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ AbstractG6 mTR−/− p53−/− MEFs exhibited 1.65 (SD 2.59) fusions per metaphase, a 3-fold increase (p = 0.012).
“By comparison, G6 mTR−/− p53−/− MEFs exhibited 1.65 (SD 2.59) fusions per metaphase, a 3-fold increase (p = 0.012).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ DiscussionIn MEFs, the cell cycle arrest occurs with stabilization and activation of p53 protein, evident in p53-dependent reporter assays and activation of p21CIP1/WAF1.
“In the case of MEFs, this arrest occurs in concert with the stabilization and activation of the p53 protein, evident in p53-dependent reporter assays and activation of p21CIP1/WAF1.”
Quote in the paperSubstantial claim- Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ AbstractSimilar differences in subcloning efficiency were observed in low-density seeding experiments.
“Similar differences were observed in low-density seeding experiments (data not shown).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Premisecitation§ IntroductionIn human cells, a critical telomere length is eventually reached that induces cellular senescence, limiting the replicative capacity of cultured cells at the Hayflick limit.
“In human cells, a critical telomere length is eventually reached that induces cellular senescence, thus limiting the replicative capacity of cultured cells at the Hayflick limit (Hayflick and Moorhead 1961”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hayflick and Moorhead 1961 source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Premisecitation§ IntroductionIn primary cells deficient for Rb and p53, continued cellular growth beyond the Hayflick limit results in severe telomere shortening, marked genetic instability, and massive cell death-a period referred to as crisis.
“In primary cells deficient for Rb and p53, continued cellular growth beyond the Hayflick limit results in severe telomere shortening, marked genetic instability, and massive cell death—a period referred to as crisis (Counter et al. 1992”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Counter et al. 1992 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ IntroductionEctopically expressed hTERT maintains telomere length and allows unlimited growth.
“Ectopically expressed hTERT maintains telomere length and allows unlimited growth (Bodnar et al. 1998; Counter et al. 1998; Vaziri and Benchimol 1998”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Premisecitation§ AbstractTelomere function may be required for immortalization, supported by frequent activation of telomerase or ALT in human cancers.
“The notion that telomere function may indeed be required for immortalization is supported by the frequent activation of telomerase or ALT in human cancers (Kim et al. 1994; Bryan et al. 1995”
Quote in the paperSubstantial claim0 of 2 sources checkedClassified as probably not a substantial claim.
Premisecitation§ IntroductionThe telomere signal that activates the senescent program operates through the RB and p53 pathways.
“The telomere signal that activates this senescent program operates through the RB and p53 pathways, since cell division beyond the Hayflick limit can occur after antisense neutralization (Hara et al. 1991”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ IntroductionTelomerase is comprised of essential catalytic (TERT) and RNA components (TR).
“Telomerase is comprised of essential catalytic (telomerase reverse transcriptase [TERT]) and RNA components (telomerase RNA [TR]) (reviewed in Greider 1998”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Greider 1998 source
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractAs mTR−/− mice advance with age and generation, an increase in cancer incidence is observed presumably due to increased genetic instability caused by telomere shortening, repeated chromosomal fusion-bridge-breakage cycles, and chromosomal loss.
“Strikingly, as mTR−/− mice advance with age and generation, an increase in cancer incidence is observed presumably due to increased genetic instability caused by telomere shortening, repeated chromosomal fusion-bridge-breakage cycles, and chromosomal loss (Rudolph et al. 1999”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rudolph et al. 1999 source
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractDue to the very long telomeres of Mus musculus, critical reduction in telomere length and chromosomal instability is only seen following extensive passage of mTR−/− cells, after successive generations of mTR−/− mice, or in aged mTR−/− organs with high proliferative histories.
“Due to the very long telomeres of Mus musculus, critical reduction in telomere length and chromosomal instability is only seen following extensive passage of mTR−/− cells (Niida et al. 1998”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ IntroductionThe RNA subunit provides the template for telomere repeat synthesis.
“The RNA subunit provides the template for telomere repeat synthesis (Greider and Blackburn 1989; Yu et al. 1990”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Greider and Blackburn 1989
Not checked in the free run.
- cites Yu et al. 1990
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ IntroductionImmortalization of some epithelial cells requires not only TERT expression but also compromise of the RB pathway.
“although immortalization of some epithelial cells requires not only TERT expression but also compromise of the RB pathway (Kiyono et al. 1998”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kiyono et al. 1998 source
Not checked in the free run.
May combine two claims.
Interpretationown data§ DiscussionAlthough loss of telomere and p53 function facilitates initiation of transformation, reconstitution of telomerase activity greatly improved the capacity of transformed foci to yield immortal cultures.
“Although loss of telomere and p53 function facilitates initiation of transformation, the reconstitution of telomerase activity greatly improved the capacity of transformed foci to yield immortal cultures.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown data§ AbstractTelomere shortening or associated chromosome fusions and breakage rather than telomerase deficiency per se signals to p53 and accounts for p21CIP1/WAF1 induction.
“Because G2 mTR−/− and G6 mTR−/− MEFs both lack telomerase activity, we conclude that telomere shortening or associated chromosome fusions and breakage rather than telomerase deficiency per se signals to p53 and accounts for p21CIP1/WAF1 induction.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationreasoning§ DiscussionThe rampant genetic instability of G7 and G8 mTR−/− p53−/− cells is associated with loss of cell viability despite p53 deficiency, implying that advanced genomic catastrophe gives way to a p53-independent process.
“Thus, the rampant genetic instability of the G7 and G8 mTR−/− p53−/− cells is associated with loss of cell viability despite p53 deficiency, implying that advanced genomic catastrophe gives way to a p53-independent process.”
Quote in the paperSubstantial claim- Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
May combine two claims.
Interpretationown data§ AbstractTelomere dysfunction acts synergistically with p53 deficiency to initiate malignant transformation, presumably by enhancing genetic instability.
“These results indicate that telomere dyfunction acts synergistically with p53 deficiency to initiate malignant transformation, presumably by enhancing genetic instability.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationreasoning§ AbstractContinued proliferation in the absence of the p53 checkpoint may lead to an increased loss of telomere sequences and account for the increased frequency of chromosome fusions.
“Continued proliferation in the absence of the p53 checkpoint may lead to an increased loss of telomere sequences and therefore account for the increased frequency of chromosome fusions.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoning§ Abstractp53 status was maintained in the heterozygous state to avoid potential broad genomic effects arising from p53 deficiency.
“For these matings, the p53 status was maintained in the heterozygous state to avoid potential broad genomic effects arising from p53 deficiency.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown data§ DiscussionThe ability of exogenous telomerase to reduce focus formation in p53 null cells with short dysfunctional telomeres suggests that genetic instability associated with telomere loss can serve as an engine driving initiation of transformation, but only in the absence of functional p53.
“The ability of exogenous telomerase to reduce focus formation in p53 null cells with short dysfunctional telomeres suggests that genetic instability associated with telomere loss can serve as an engine driving initiation of transformation, but only in the absence of functional p53 (Figure 5).”
Quote in the paperSubstantial claim- Rests on an assumption: Focus formation reflects the earliest stages of oncogenic transformation.
May combine two claims.
Interpretationreasoning§ DiscussionEarly crisis accounts for efficient germ cell depletion in G6 mTR−/− p53+/+, whereas altered histology of G7 and G8 mTR−/− p53−/− testis provides experimental support for late crisis.
“Early crisis accounts for efficient germ cell depletion in G6 mTR−/− p53+/+, whereas the altered histology of G7 and G8 mTR−/− p53−/− testis provides experimental support for late crisis.”
Quote in the paperSubstantial claim- Rests on an assumption: The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
May combine two claims.
Interpretationown data§ Abstractp53 deficiency restores neither telomere length nor function in the telomerase-deficient mouse.
“Together, these data indicate that p53 deficiency restores neither telomere length nor function in the telomerase-deficient mouse.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoning§ AbstractThe mating scheme produced p53+/+ and p53−/− littermate controls for each mTR−/− generation.
“This mating scheme also produced p53+/+ and p53−/− littermate controls for each mTR−/− generation.”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitation§ AbstractTelomere shortening in mTR−/− mice results in loss of telomere function and chromosome end-to-end fusion.
“Telomere shortening in mTR−/− mice results in loss of telomere function and chromosome end-to-end fusion (Blasco et al. 1997; Rudolph et al. 1999”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Interpretationown data§ DiscussionmTR expression facilitates subcloning efficiency of Myc/RAS-transformed late-generation mTR−/− cells, supporting the importance of telomere maintenance mechanisms during later stages of carcinogenesis.
“The observation that mTR expression facilitates subcloning efficiency of Myc/RAS-transformed late-generation mTR−/− cells supports the importance of telomere maintenance mechanisms during later stages of carcinogenesis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ AbstractInduction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to rapid stabilization of p53 through phosphorylation of its N terminus.
“Induction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to the rapid stabilization of p53 through phosphorylation of its N terminus (Shieh et al. 1997; Siliciano et al. 1997”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Interpretationreasoning§ DiscussionDuring the early stages of tumorigenesis, cells suffer telomere shortening, and telomerase activation is advantageous primarily in later stages of tumorigenesis.
“Together with previous work, our data indicated that, first, during the early stages of tumorigenesis, cells suffer telomere shortening, and second, that telomerase activation is advantageous primarily in later stages of tumorigenesis.”
Quote in the paperSubstantial claim- Rests on an assumption: Many human tumors that are telomerase positive still have short telomeres.
May combine two claims.
Interpretationreasoning§ AbstractCells with short telomeres and intact p53-mediated DNA damage responses may be more efficiently culled from the population, therefore p53 null cells may accumulate more end-to-end fusions than their p53+/+ counterparts.
“Cells with short telomeres and intact p53-mediated DNA damage responses may be more efficiently “culled” from the population (via apoptosis or arrest); therefore, p53 null cells may accumulate more end-to-end fusions than their p53+/+ counterparts.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationreasoning§ DiscussionOnce both telomere function and p53 have been impaired, the fate of the cell is unpredictable and depends on other stochastic genetic changes.
“Once both telomere function and p53 have been impaired, the fate of the cell is unpredictable and depends on other stochastic genetic changes.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Premisecitation§ Abstractp53 stabilization results in either cell cycle arrest via transcriptional induction of the p21CIP1/WAF1 CDK inhibitor or apoptosis.
“This stabilization results in either cell cycle arrest via transcriptional induction of the p21CIP1/WAF1 CDK inhibitor or apoptosis (reviewed in Levine 1997”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Levine 1997 source
Not checked in the free run.
May combine two claims.
Interpretationreasoning§ DiscussionLoss of p53 can circumvent the early crisis checkpoint, leading eventually to p53-independent apoptosis, perhaps as a consequence of uncontrolled chromosome fusion-bridge-breakage cycles and progressive genomic instability.
“Loss of p53 can circumvent this checkpoint, leading eventually to p53-independent apoptosis, perhaps as a consequence of uncontrolled chromosome fusion-bridge-breakage cycles and progressive genomic instability.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown data§ AbstractBoth the apoptotic response and cell cycle arrest induced by telomere dysfunction are mediated by p53.
“Thus, both the apoptotic response and cell cycle arrest induced by telomere dysfunction are mediated by p53.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ DiscussionFor telomere length determination of MEFs, littermate MEF cultures were assayed simultaneously to reduce experimental variability.
“For telomere length determination of MEFs, littermate MEF cultures were assayed simultaneously to reduce experimental variability.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ DiscussionAt least two independent determinations of the same cultures were performed for telomere length.
“At least two independent determinations of the same cultures were performed.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ DiscussionDay to day variations in the linearity of the flow cytometer were controlled by the use of FITC-labeled fluorescence beads.
“Day to day variations in the linearity of the flow cytometer were controlled by the use of FITC-labeled fluorescence beads (Flow Cytometry Standards Corporation).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ DiscussionFor primary thymocytes, three independent age-matched sets of animals were used.
“Three independent age-matched sets of animals were used.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationreasoning§ DiscussionIn mTR−/− INK4a−/− mice, telomere dysfunction likely activates p53 via a DNA damage signaling pathway and results in growth arrest or apoptosis, limiting the efficiency of carcinogenesis.
“In mTR−/− INK4a−/− mice, it is likely that telomere dysfunction activates p53 via a DNA damage signaling pathway and results in growth arrest or apoptosis, limiting the efficiency of carcinogenesis”
Quote in the paperSubstantial claim
The paper relies on this without support.
The signals and pathways mediating the cellular responses associated with telomere dysfunction have yet to be defined in mammalian cells.
“The signals and pathways mediating these cellular responses associated with telomere dysfunction have yet to be defined in mammalian cells.”
The paper relies on this without support.
The RAD9 and MEC1 DNA damage response pathways in yeast are similar to the p53 checkpoint in mammalian cells.
“The RAD9 and MEC1 DNA damage response pathways in yeast are thought to be similar to the p53 checkpoint in mammalian cells.”
The paper relies on this without support.
The mTR−/− mouse is a valid model for studying the consequences of telomere loss in vivo.
“The mTR−/− mouse serves as a model to study the consequences of telomere loss in vivo.”
The paper relies on this without support.
Focus formation reflects the earliest stages of oncogenic transformation.
“Focus formation is thought to reflect the earliest stages of oncogenic transformation.”
The paper relies on this without support.
Human cells require inactivation of Rb and/or p53 to bypass the major checkpoint that limits replicative lifespan: cellular senescence.
“Human cells require inactivation of Rb and/or p53 to bypass the major checkpoint that limits replicative lifespan: cellular senescence.”
The paper relies on this without support.
Rb/p53 inactivation allows continued cell division beyond senescence, progressive telomere shortening, and entry into crisis, from which only rare survivors emerge.
“Rb/p53 inactivation allows continued cell division beyond senescence, progressive telomere shortening, and entry into crisis, from which only rare survivors will emerge.”
The paper relies on this without support.
Many human tumors that are telomerase positive still have short telomeres.
“The fact that many human tumors that are telomerase positive still have short telomeres supports the idea that telomerase activation occurs late in tumorigenesis.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
mTerc-/- p53 mutant mice experience a dramatic increase in cancer incidence, a shift in tumor spectrum toward epithelial cancers, and accumulation of marked chromosomal aberrations targeting cancer-relevant loci.
“Although enabling cellular growth and survival and masking degenerative phenotypes, these mTerc -/ -p53 mutant mice experience a dramatic increase in cancer incidence, shift in tumor spectrum toward epithelial cancers, and accumulation of marked chromosomal aberrations targeting cancerrelevant loci for amplification and deletion (4-6).”
From <i>Ink4a</i> / <i>Arf</i> tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [4]
In the section on tumorigenic initiation and progression (page unavailable), the paper reports a threefold increase in chromosome fusions in mTR−/− p53−/− mouse embryo fibroblasts; the Discussion also reports that telomere dysfunction and p53 deficiency facilitate cellular transformation. These findings do not establish the claimed dramatic increase in cancer incidence or shift toward epithelial cancers in the mice, nor do the passages identify aberrations targeting specific cancer-relevant loci for amplification or deletion. (LLM, conf=0.86)
Experimental — accuracy not yet measuredp53 deficiency in mTerc-/- mice results in near-complete rescue of adverse cellular consequences associated with telomere dysfunction, including cellular growth arrest and apoptosis, progressive organ system atrophy, and physiological compromise.
“Specifically, p53 deficiency results in nearcomplete rescue of adverse cellular consequences associated with telomere dysfunction, including cellular growth arrest and apoptosis, progressive organ system atrophy, and physiological compromise.”
From <i>Ink4a</i> / <i>Arf</i> tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [4]
The Abstract (page unavailable) says p53 deletion significantly attenuated the cellular and organismal effects of telomere dysfunction, but only during the earliest stages of genetic crisis. The testis findings (page unavailable) show near-normal size and markedly reduced apoptosis in some generations, while G7–G8 p53-deficient mice still showed significant germ-cell depletion. Thus the unqualified claim of near-complete rescue across the listed consequences overstates the paper. (LLM, conf=0.88)
Experimental — accuracy not yet measuredTelomere dysfunction appears to engage the p53-dependent double-stranded break DNA damage pathway.
“Telomere dysfunction appears to engage the p53-dependent double-stranded break DNA damage pathway.”
From <i>Ink4a</i> / <i>Arf</i> tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [4]
The Discussion ('Telomere Dysfunction Activates a p53-Dependent Checkpoint'; page not provided) says telomere loss activates a p53-dependent response similar to DNA-damage checkpoints. The paper also describes p53 stabilization after double-strand breaks, but does not establish that telomere dysfunction engages that specific double-strand-break pathway. (LLM, conf=0.83)
Experimental — accuracy not yet measuredWhen the p53 checkpoint is compromised, unchecked genomic instability caused by telomere dysfunction accelerates tumorigenesis as seen in late-generation mTerc-/- p53 mutant mice.
“When the p53 checkpoint is compromised, unchecked genomic instability caused by telomere dysfunction accelerates tumorigenesis as seen in late-generation mTerc -/ -p53 mutant mice (4, 5).”
From <i>Ink4a</i> / <i>Arf</i> tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [4]
The section headed “Tumorigenic Initiation and Progression in the Setting of Telomere Dysfunction and p53 Deficiency” reports that telomere dysfunction and p53 deficiency cooperated to initiate malignant transformation in fibroblasts from late-generation mTR−/− p53−/− mice. It describes enhanced genetic instability as a presumed mechanism. It does not establish accelerated tumorigenesis in the mice themselves; its tumorigenesis evidence comes from a Myc/RAS transformation assay. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measuredIn mice, p53 inactivation alone is sufficient to avoid telomere-induced senescence and apoptosis.
“By contrast, p53 inactivation alone is sufficient to avoid telomere-induced senescence and apoptosis in mice49,50.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [49]
Without telomerase, continued cell division leads to telomere shortening, loss of capping function, and p53 activation.
“In the absence of telomerase, continued cell division results in telomere shortening, loss of ‘capping’ function, and p53 activation12-15.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [15]
p53 deficiency attenuates degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes.
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [15]
Critically short telomeres cause cellular and tissue defects through checkpoint signaling pathways that converge on p53.
“Critically short telomeres induce cellular and tissue defects through checkpoint signaling pathways that converge on the p53 tumor suppressor protein, a well-known cellular stress sensor that enforces cell cycle arrest or cell death in response to diverse stimuli including activated oncogenes, DNA damage and hypoxia (69)”
From Telomeres and telomerase in cancer (2010) · cites this paper as [69]
Telomere-induced senescence acts mainly through p53-dependent pathways, though the RB pathway may also be involved in some contexts.
“The downstream effector pathways of telomere-induced senescence are largely p53-dependent96, but there may be involvement of the retinoblastoma protein (RB) pathway in some settings97.”
From The telomere syndromes (2012) · cites this paper as [96]
Removal of p53 function rescued many cellular defects despite critically short telomeres, including growth arrest in cell culture, testicular atrophy, intestinal and germ cell apoptosis.
“Importantly, removal of p53 function rescued many of the cellular defects despite the presence of critically short telomeres, including growth arrest in cell culture, testicular atrophy, intestinal and germ cell apoptosis46.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [46]
Recent reports of the effect of the mTR deletion in different genetic backgrounds suggest that the role of telomerase in cancer development could be highly context dependent.
“recent reports of the effect of the mTR deletion in different genetic backgrounds (17, 18) suggest that the role of telomerase in cancer development could be highly context dependent (19).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [18]
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · see citing works
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · see citing works
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · cited 1× · see citing works
“INK4a2/2 centration of 10 mM for 3.5 hr. Cells were processed as previouslymice lack functional p19ARF, a modulator of p53 function described (Serrano et al., 1997).activated by inappropiate oncogene activation, but re- tain intact DNA damage–induced p53 activation (Kamijo MEF Transformation…”
MethodInfluentialExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975 · see citing works
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,911 · see citing works
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · see citing works
Requirement for p53 and p21 to Sustain G <sub>2</sub> Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · see citing works
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113 · see citing works
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108 · see citing works
Self-citationDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · see citing works
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096 · cited 2× · see citing works
“cence checkpoint (Counter et al., 1992).”
BackgroundSelf-citationTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709 · see citing works
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643 · see citing works
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566 · see citing works
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · see citing works
Self-citationLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349 · cited 7× · see citing works
“Telomere shortening in mTR2/2 mice results in loss of As telomere function worsens in later generations of telomere function and chromosome end-to-end fusion mTR deficiency, germ cell death by p53-independent (Blasco et al., 1997; Rudolph et al., 1999).”
BackgroundResultInfluentialSelf-citationTelomere elongation in immortal human cells without detectable telomerase activity
Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S., & Reddel, R. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00098.x · Cited by 1,279 · see citing works
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 14× · see citing works
“The geno-in reproductive competence in late-generation (G6) mTR2/2 p531/1 mice (Lee et al., 1998).”
BackgroundInfluentialSelf-citationRadiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 2× · see citing works
“Consistent with the established role of p53 and 21 atrophy Normal p21 in mediating a biphasic arrest in response to 21 atrophy 11 atrophy DNA damage signals (Brugarolas et al., 1995; Deng et 31 atrophy 21 atrophy al., 1995; Bunz et al., 1998) loss of p53 abrogated this Normal 21 atrophy”
BackgroundControl of telomere length by the human telomeric protein TRF1
van Steensel, B., & de Lange, T. (1997) · Nature · doi:10.1038/385740a0 · Cited by 1,219 · see citing works
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206 · see citing works
p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086 · see citing works
Vaziri, H., & Benchimol, S. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70109-5 · Cited by 1,003 · see citing works
An alternative pathway for yeast telomere maintenance rescues est1− senescence
Lundblad, V., & Blackburn, E. H. (1993) · Cell · doi:10.1016/0092-8674(93)90234-h · Cited by 942 · see citing works
Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression
Kern, S. E., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K. W., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940 · see citing works
DNA damage induces phosphorylation of the amino terminus of p53
Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B. (1997) · Genes & Development · doi:10.1101/gad.11.24.3471 · Cited by 818 · see citing works
Loss of a yeast telomere: Arrest, recovery, and chromosome loss
Sandell, L. J. (1993) · Cell · doi:10.1016/0092-8674(93)90493-a · Cited by 787 · see citing works
A role for both RB and p53 in the regulation of human cellular senescence*1
SHAY, J. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90453-2 · Cited by 757 · see citing works
Counter, C. M., Hahn, W. C., Wei, W., Caddle, S. D., Beijersbergen, R. L., Lansdorp, P. M., Sedivy, J. M., & Weinberg, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14723 · Cited by 649 · see citing works
Yu, G.-L., Bradley, J. D., Attardi, L. D., & Blackburn, E. H. (1990) · Nature · doi:10.1038/344126a0 · Cited by 632 · see citing works
Prives, C. (1998) · Cell · doi:10.1016/s0092-8674(00)81774-2 · Cited by 623 · see citing works
A subset of p53-deficient embryos exhibit exencephaly
Sah, V. P., Attardi, L. D., Mulligan, G., Williams, B. O., Bronson, R. T., & Jacks, T. (1995) · Nature Genetics · doi:10.1038/ng0695-175 · Cited by 579 · see citing works
Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry
Rufer, N., Dragowska, W. H., Thornbury, G., Roosnek, E. E., & Lansdorp, P. M. (1998) · Nature Biotechnology · doi:10.1038/nbt0898-743 · Cited by 547 · see citing works
(1993) · PubMed · Cited by 469 · see citing works
Venkatachalam, S., Shi, Y., Jones, S. N., Vogel, H. S., Bradley, A., Pinkel, D., & Donehower, L. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4657 · Cited by 449 · see citing works
Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
Greenberg, R. A., Chin, L., Femino, A., Lee, K.-H., Gottlieb, G. J., Singer, R. H., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80761-8 · Cited by 367 · see citing works
Self-citationHara, E., Tsurui, H., Shinozaki, A., Nakada, S., & Oda, K. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91403-y · Cited by 260 · see citing works
McEachern, M. J., & Blackburn, E. H. (1996) · Genes & Development · doi:10.1101/gad.10.14.1822 · Cited by 224 · see citing works
Telomeres and senescence: The history, the experiment, the future
Greider, C. W. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70105-8 · Cited by 191 · see citing works
Self-citationGottlieb, E., Haffner, R., King, A., Asher, G., Gruss, P., Lonai, P., & Oren, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1381 · Cited by 164 · see citing works
Severe growth defect in mouse cells lacking the telomerase RNA component
Niida, H., Matsumoto, T., Satoh, H., Shiwa, M., Tokutake, Y., Furuichi, Y., & Shinkai, Y. (1998) · Nature Genetics · doi:10.1038/580 · Cited by 156 · cited 1× · see citing works
“…musculus, critical reduction in telomere length and chro-Introduction mosomal instability is only seen following extensive passage of mTR2/2 cells (Niida et al., 1998), after successiveTelomeres are nucleoprotein structures that serve a critgenerations of mTR2/2 mice (Blasco et al., 1997; Lee…”
BackgroundTelomere shortening in mTR−/− embryos is associated with failure to close the neural tube
Herrera, E., Samper, E., & Blasco, M. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1172 · Cited by 147 · see citing works
Mukherjee, B., Morgenbesser, S. D., & DePinho, R. A. (1992) · Genes & Development · doi:10.1101/gad.6.8.1480 · Cited by 125 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,784 · see citing works
“It has been well established that telomerase is not active in most somatic tissues; therefore, telomeres shorten gradually with age, both in vitro and in vivo, and such erosion is sensed by the cells as a clock to switch toward a p53-mediated senescence program (Chin et al., 1999).”
BackgroundShelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · see citing works
“For instance, p53-deficient mice better tolerate the consequences of telomere shortening in the later generations of telomerase-deficient mice (Chin et al. 1999).”
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc776 · Cited by 2,073 · see citing works
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · see citing works
“In the absence of p53, however, telomere dysfunction instead promotes tumorigenesis (Chin et al. 1999).”
BackgroundLowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,867 · see citing works
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · see citing works
“The two main exceptions to this general trend occur when lack of telomerase is combined with a deficiency in p53 (Chin et al., 1999) or with overexpression of the telomerebinding protein TRF2, which recruits the nuclease XPF to telomeres and degrades them (Blanco et al.”
Telomeres and human disease: ageing, cancer and beyond
Blasco, M. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1656 · Cited by 1,690 · see citing works
“Further selection for tumour cells that have reactivated telomerase (>90% of human cancers) would then guarantee their indefinite growth potential by rescuing short telomeres and preventing MITOTIC CATASTROPHE”
BackgroundGenetics and biology of pancreatic ductal adenocarcinomaPreprint
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N. M., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,570 · see citing works
Self-citationp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · see citing works
DNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409 · see citing works
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319 · see citing works
Self-citationSenescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233 · see citing works
“Similarly, p53−/− can ameliorate some of the effects of severe progeria mutants such as Ku80−/−, mTR−/−, and Zmpste24−/− (Chin et al., 1999; Lim et al., 2000; Varela et al., 2005), but the resulting increase in tumorigenesis obscures potential increases in life span.”
Hemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219 · see citing works
Self-citationPancreatic cancer biology and genetics
Bardeesy, N. M., & DePinho, R. A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc949 · Cited by 1,144 · see citing works
“The survival of cells with critically short telomeres (crisis), which continue to go through breakage–fusion–bridge events, is enhanced by inactivation of the p53-dependent DNA-damage respons”
BackgroundSelf-citationTelomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085 · see citing works
“In the setting of p53 deficiency, telomere dysfunction confers a greater susceptibility to transformation by cellular oncogene”
BackgroundSelf-citationAguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1158703 · Cited by 1,033 · see citing works
“…differences in telomere dynamics (Maser and DePinho 2002), the prominent role of p53 (and not ARF) in the telomere checkpoint response of evolving tumors (Chin et al. 1999), and evidence of telomere dysfunction in the progression of human pancreatic adenocarcinoma (van Heek et al. 2002).”
BackgroundSelf-citationA p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., & Blasco, M. A. (2009) · Nature · doi:10.1038/nature08287 · Cited by 1,028 · see citing works
Spontaneous Human Adult Stem Cell Transformation
Rubio, D., Garcı́a-Castro, J., Martín, M. C., de la Fuente, R., Cigudosa, J. C., Lloyd, A. C., & Bernad, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4194 · Cited by 1,030 · see citing works
“If cells bypass this stage, they continue to grow until telomeres become critically short and cells enter crisis phase, characterized by generalized chromosome instability that provokes mass apoptosis (5).”
BackgroundRetractedAlternative lengthening of telomeres: models, mechanisms and implications
Cesare, A. J., & Reddel, R. R. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2763 · Cited by 1,022 · see citing works
“Given that p53 acts in the major response pathway to telomere dysfunction and that loss of p53 is required for cells to be refractory to telomere DDR-induced cell cycle arres”
BackgroundInhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E. N., Kurachi, A. L., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M. M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,032 · see citing works
“Furthermore, p53 has been suggested to be one participant in the cellular response to telomere disruption and los”
Telomeres: protecting chromosomes against genome instability
O’Sullivan, R. J., & Karlseder, J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2848 · Cited by 994 · see citing works
“Consequently, it was suggested that the loss of telomerase and p53 cooperate to promote cellular transformatio”
BackgroundArmanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982 · see citing works
Modelling the molecular circuitry of cancer
Hahn, W. C., & Weinberg, R. A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc795 · Cited by 936 · see citing works
Protection of mammalian telomeres
de Lange, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205080 · Cited by 942 · see citing works
Stems Cells and the Pathways to Aging and Cancer
Rossi, D. J., Jamieson, C. H. M., & Weissman, I. L. (2008) · Cell · doi:10.1016/j.cell.2008.01.036 · Cited by 895 · see citing works
“…of p53 acts positively upon the germ cell compartment in young telomerase-deficient mice yet exacerbates tumorigenesis later in life, which is likely due to the fact that p53 deficiency rescues both the proliferative defect and apoptosis associated with telomere dysfunction (Chin et al., 1999).”
BackgroundA crucial role for adipose tissue p53 in the regulation of insulin resistance
Minamino, T., Orimo, M., Shimizu, I., Kunieda, T., Yokoyama, M., Ito, T., Nojima, A., Nabetani, A., Oike, Y., Matsubara, H., et al. (2009) · Nature Medicine · doi:10.1038/nm.2014 · Cited by 891 · see citing works
“It is well accepted that dysfunctional (that is, critically short) telomeres resemble damaged DNA and thus trigger a p53-dependent respons”
BackgroundHow stem cells age and why this makes us grow old
Sharpless, N. E., & DePinho, R. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2241 · Cited by 843 · see citing works
Self-citationTelomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823 · see citing works
Self-citationSenescence and aging: the critical roles of p53
Rufini, A., Tucci, P., Celardo, I., & Melino, G. (2013) · Oncogene · doi:10.1038/onc.2012.640 · Cited by 798 · see citing works
Telomeres in cancer: tumour suppression and genome instability
Maciejowski, J., & de Lange, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.171 · Cited by 745 · see citing works
Linking functional decline of telomeres, mitochondria and stem cells during ageing
Sahin, E., & DePinho, R. A. (2010) · Nature · doi:10.1038/nature08982 · Cited by 759 · see citing works
Self-citationTelomere length, stem cells and aging
Blasco, M. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.38 · Cited by 747 · see citing works
“As an exception to this, telomerase deficiency and short telomeres in the context of p53 mutant mice and in the context of TRF2 overexpression lead to a further increase of epithelial tumors characterized by high levels of chromosomal instability, which suggests that mutation of these pathways helps bypass the barrier…”
Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745 · see citing works
“On the other hand, observations that late-generation mTR null cells mTR null animals, the levels of p53 and p53-responsive with shortened telomeres (Chin et al., 1999) or cells with otherwise disrupted telomere structures (Karlseder et al., 1999) initiate p53-dependent DNA damage responses lend…”
BackgroundSelf-citationMaximizing mouse cancer models
Frese, K. K., & Tuveson, D. A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2192 · Cited by 711 · see citing works
Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
Zhang, X., Mar, V., Zhou, W., Harrington, L., & Robinson, M. O. (1999) · Genes & Development · doi:10.1101/gad.13.18.2388 · Cited by 698 · see citing works
“In contrast, combination of lack of telomerase activity and p53 deficiency in mTR/p53 null mice also cooperated to initiate tumor formation in aging mTR null mice (Chin et al. 1999).”
BackgroundTelomeres, lifestyle, cancer, and aging
Shammas, M. A. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834121b1 · Cited by 685 · see citing works
Alternative lengthening of telomeres in mammalian cells
Henson, J. D., Neumann, A. A., Yeager, T. R., & Reddel, R. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205058 · Cited by 660 · see citing works
Telomeres: history, health, and hallmarks of aging
Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637 · see citing works
“In lategeneration TERT- or TERC-null mice, progressive telomere erosion leads to p53-dependent apoptotic elimination of tissue stem cells, which contributes to organ atrophy, particularly in highly proliferative tissues with high rates of self-renewal, including the skin, intestine, testis, regenerating injured liver,…”
InfluentialSelf-citationThe effects of aging in the hippocampus and cognitive decline
Bettio, L. E. B., Rajendran, L., & Gil‐Mohapel, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.030 · Cited by 654 · see citing works
“With the eventual loss of telomeric function, cellular senescence or apoptosis occurs through the activation of a DNA damage response that includes the induction of tumor suppressor protein p53- and retinoblastoma protein (pRB)mediated signaling pathways (Chin et al., 1999; Deng et al., 2008).”
DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion
Celli, G. B., & de Lange, T. (2005) · Nature Cell Biology · doi:10.1038/ncb1275 · Cited by 623 · see citing works
“This arrest was abrogated by p53 deficiency, consistent with previous finding”
Defective Telomere Lagging Strand Synthesis in Cells Lacking WRN Helicase Activity
Crabbé, L., Verdún, R. E., Haggblom, C., & Karlseder, J. (2004) · Science · doi:10.1126/science.1103619 · Cited by 604 · see citing works
Mechanisms of Stem Cell Self-Renewal
He, S., Nakada, D., & Morrison, S. J. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113248 · Cited by 607 · see citing works
Redox regulation of mitochondrial function
Handy, D. E., & Loscalzo, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4123 · Cited by 588 · see citing works
“One role of telomeres is to suppress p53 activation (84).”
Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes
Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., & Tlsty, T. D. (2001) · Nature · doi:10.1038/35054579 · Cited by 560 · see citing works
Connecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561 · see citing works
Self-citationAging and Genome Maintenance: Lessons from the Mouse?
Hasty, P., Campisi, J., Hoeijmakers, J., van Steeg, H., & Vijg, J. (2003) · Science · doi:10.1126/science.1079161 · Cited by 553 · see citing works
Short- and long-term effects of chromosome mis-segregation and aneuploidy
Santaguida, S., & Amon, A. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4025 · Cited by 535 · see citing works
Mitochondrial dysfunction and oxidative stress in aging and cancer
Kudryavtseva, A. V., Krasnov, G. S., Dmitriev, A. A., Alekseev, B. Y., Kardymon, O. L., Садритдинова, А. Ф., Fedorova, M., Pokrovsky, A. V., Melnikova, N. V., Каприн, А. Д., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9821 · Cited by 551 · see citing works
“For example, a study of a telomerase-knockout mouse, heterozygous for mutant p53, revealed that a loss of telomere function and the consequent genomic instability could cooperate with p53 deficiency and promote tumorigenic initiation [336].”
BackgroundHerbert, B.-S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., & Corey, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14276 · Cited by 539 · see citing works
Invited Review: Theories of aging
Weinert, B. T., & Timiras, P. S. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00288.2003 · Cited by 530 · see citing works
“The tumor suppressor protein p53 is required for cellular senescence; p53 deficiency suppresses the early aging phenotype of late-generation telomerasedeficient mice (16).”
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0977com · Cited by 527 · see citing works
Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · see citing works
“Checkpoint responses that are dependent on p53 underlie the adverse cellular consequences of telomere dysfunctio”
BackgroundSelf-citationTelomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Martínez, P., & Blasco, M. A. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3025 · Cited by 530 · see citing works
Punctuated copy number evolution and clonal stasis in triple-negative breast cancer
Gao, R., Davis, A., McDonald, T. O., Sei, E., Shi, X., Wang, Y., Tsai, P. C., Casasent, T. D., Waters, J., Zhang, H., et al. (2016) · Nature Genetics · doi:10.1038/ng.3641 · Cited by 516 · see citing works
Human Endothelial Cell Life Extension by Telomerase Expression
Yang, J., Chang, E., Cherry, A. M., Bangs, C. D., Oei, Y. A., Bodnar, A. G., Bronstein, A., Chiu, C., & Herron, G. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26141 · Cited by 499 · see citing works
Hallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502 · see citing works
“Late-generation telomerase-deficient mice show severe proliferative defects leading to immune dysfunction and failure to reproduce (Blasco et al., 1997; Lee et al., 1998; Chin et al., 1999; Rudolph et al., 1999).”
Telomere Dysfunction: A Potential Cancer Predisposition Factor
Wu, X., Amos, C. I., Zhu, Y., Zhao, H., Grossman, B. H., Shay, J. W., Luo, S., Hong, W. K., & Spitz, M. R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg011 · Cited by 488 · see citing works
“Similarly, Chin et al. ( 16 ) found that, concurrent with severe telomere shortening and genomic instability, p53 was activated, leading to growth arrest and/or apoptosis.”
Different telomere damage signaling pathways in human and mouse cells
Smogorzewska, A., & de Lange, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf433 · Cited by 482 · see citing works
Telomeres, stem cells, senescence, and cancer
Sharpless, N. E., & DePinho, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20761 · Cited by 479 · see citing works
“Correspondingly, p53 loss greatly attenuates the apoptotic phenotype seen in proliferative organs in the setting of telomere dysfunction in animal models (37).”
Self-citationRole of Oxidative Stress in Telomere Length Regulation and Replicative Senescence
von Zglinicki, T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06639.x · Cited by 445 · see citing works
Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1
Itahana, K., Zou, Y., Itahana, Y., Martinez, J.-L., Beausejour, C., Jacobs, J. J. L., van Lohuizen, M., Band, V., Campisi, J., & Dimri, G. P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.389-401.2003 · Cited by 438 · see citing works
“p53 is thought to mediate the senescence response to telomere dysfunction (3, 6, 12, 26, 49, 67), although a p53-dependent but telomere-independent senescence pathway was recently identified in human keratinocytes (46).”
BackgroundInhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery
Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N., & DePinho, R. A. (2000) · Science · doi:10.1126/science.287.5456.1253 · Cited by 424 · see citing works
Self-citationRoberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1270 · Cited by 428 · see citing works
“A pivotal element to this hypothesis is p53, postulated to mediate replicative arrest in response to a DNA damage signal produced by a sufficiently short telomere (3, 4).”
Choudhury, A. R., Ju, Z., Djojosubroto, M. W., Schienke, A., Lechel, A., Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1937 · Cited by 426 · see citing works
“but also increases genomic instability and cancer formation in vivo , thus reducing the lifespan of mice with dysfunctional telomere”
Examination of the expanding pathways for the regulation of p21 expression and activity
Jung, Y.-S., Qian, Y., & Chen, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.013 · Cited by 418 · see citing works
Putting the stress on senescence
Serrano, M., & Blasco, M. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00278-7 · Cited by 413 · see citing works
Telomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411 · see citing works
“Importantly, despite the presence of critically short telomeres, removal of p53 function rescued many of the cellular defects, including growth arrest in cell culture, testicular atrophy and intestinal and germ-cell apoptosi”
DNA damage responses and p53 in the aging process
Ou, H.-L., & Schumacher, B. (2018) · Blood · doi:10.1182/blood-2017-07-746396 · Cited by 377 · see citing works
Troen, B. R. (2003) · PubMed · Cited by 403 · see citing works
Wright, W. E., & Shay, J. W. (2000) · Nature Medicine · doi:10.1038/78592 · Cited by 398 · see citing works
Cellular senescence, cancer and aging: the telomere connection
Campisi, J., Kim, S.-H., Lim, C.-S., & Rubio, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00160-7 · Cited by 400 · see citing works
DNA damage checkpoints in stem cells, ageing and cancer
Sperka, T., Wang, J., & Rudolph, K. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3420 · Cited by 393 · see citing works
Two faces of p53: aging and tumor suppression
Rodier, F., Campisi, J., & Bhaumik, D. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm744 · Cited by 399 · see citing works
Telomere Dysfunction Increases Mutation Rate and Genomic Instability
Hackett, J. A., Feldser, D. M., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00457-3 · Cited by 380 · see citing works
Self-citationAxis of ageing: telomeres, p53 and mitochondria
Sahin, E., & DePinho, R. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3352 · Cited by 380 · see citing works
Self-citationPhysical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall
Werner, C., Fürster, T., Widmann, T., Pöss, J., Roggia, C., Hanhoun, M., Scharhag, J., Büchner, N., Meyer, T., Kindermann, W., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.861005 · Cited by 380 · see citing works
How ageing processes influence cancer
de Magalhães, J. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3497 · Cited by 367 · see citing works
Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing
Wong, K.-K., Maser, R. S., Bachoo, R. M., Menon, J., Carrasco, D. R., Gu, Y., Alt, F. W., & DePinho, R. A. (2003) · Nature · doi:10.1038/nature01385 · Cited by 375 · see citing works
Self-citationChromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Maser, R. S., Choudhury, B., Campbell, P. J., Feng, B., Wong, K.-K., Protopopov, A., O’Neil, J., Gutierrez, A., Ivanova, E., Perna, I., et al. (2007) · Nature · doi:10.1038/nature05886 · Cited by 377 · see citing works
Self-citationShort Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
Greenberg, R. A., Chin, L., Femino, A., Lee, K.-H., Gottlieb, G. J., Singer, R. H., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80761-8 · Cited by 367 · see citing works
Self-citationTelomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia
van Heek, N. T., Meeker, A. K., Kern, S. E., Yeo, C. J., Lillemoe, K. D., Cameron, J. L., Offerhaus, G. J. A., Hicks, J. L., Wilentz, R. E., Goggins, M. G., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64432-x · Cited by 363 · see citing works
The role of DNA breaks in genomic instability and tumorigenesis
Mills, K. D., Ferguson, D. O., & Alt, F. W. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00060.x · Cited by 361 · see citing works
“Recently, the mouse model of telomere erosion described above has provided compelling evidence that the substantial genome instability resulting from telomere failure can directly contribute to tumorigenesis (88, 89).”
BackgroundHistorical claims and current interpretations of replicative aging
Wright, W. E., & Shay, J. W. (2002) · Nature Biotechnology · doi:10.1038/nbt0702-682 · Cited by 355 · see citing works
““Too-short” telomeres combined with p53 mutations produce genomic instability and an increased malignant conversion in telomerase-null mic”
BackgroundNatural and pharmacological regulation of telomerase
Mergny, J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.839 · Cited by 351 · see citing works
Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
González-Suárez, E., Samper, E., Flores, J. M., & Blasco, M. A. (2000) · Nature Genetics · doi:10.1038/79089 · Cited by 347 · see citing works
“The appearance of these tumours is thought to be a consequence of chromosomal instability in these mic”
Kyo, S., Takakura, M., Fujiwara, T., & Inoue, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00878.x · Cited by 347 · see citing works
Telomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. Y. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 346 · see citing works
Chromosomal instability in ulcerative colitis is related to telomere shortening
O'Sullivan, J. N., Bronner, M. P., Brentnall, T. A., Finley, J. C., Shen, W.-T., Emerson, S., Emond, M. J., Gollahon, K. A., Moskovitz, A. H., Crispin, D. A., et al. (2002) · Nature Genetics · doi:10.1038/ng989 · Cited by 346 · see citing works
A Differentiation Checkpoint Limits Hematopoietic Stem Cell Self-Renewal in Response to DNA Damage
Wang, J., Sun, Q., Morita, Y., Jiang, H., Groß, A., Lechel, A., Hildner, K., Guachalla, L. M., Gompf, A., Hartmann, D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.040 · Cited by 343 · see citing works
Mechanisms of cellular senescence in human and mouse cells.
Itahana, K., Campisi, J., & Dimri, G. P. (2004) · Biogerontology · doi:10.1023/b:bgen.0000017682.96395.10 · Cited by 338 · see citing works
“of Myc and RAS in MEFs derived from sixth generation mTR−/− p53+/− mice (Chin et al. 1999).”
InfluentialTelomere dysfunction causes alveolar stem cell failure
Alder, J. K., Barkauskas, C. E., Limjunyawong, N., Stanley, S. E., Kembou, F., Tuder, R. M., Hogan, B. L. M., Mitzner, W., & Armanios, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504780112 · Cited by 339 · see citing works
Ceccaldi, R., Parmar, K., Mouly, E., Delord, M., Kim, J. M., Regairaz, M., Pla, M., Vasquez, N., Zhang, Q., Pondarré, C., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.013 · Cited by 342 · see citing works
“In dyskeratosis congenita, a defect in telomere metabolism and subsequent progressive telomere shortening triggers p53-induced senescence, leading to a delayed BMF in patients (Bellodi et al., 2010; Chin et al., 1999).”
BackgroundTelomerase: A target for cancer therapeutics
Shay, J. W., & Wright, W. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00159-9 · Cited by 330 · see citing works
“While there is some experimental animal model evidence in support of this, especially in p53-deficient tumors (Chin et al., 1999; GonzalezSuarez et al., 2001), most of the experiments treating human cancer cell lines with telomerase inhibitors and experimental models producing progressively shortened telomeres indicat…”
BackgroundMechanisms that Regulate Stem Cell Aging and Life Span
Signer, R. A. J., & Morrison, S. J. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.001 · Cited by 320 · see citing works
Constitutive telomerase expression promotes mammary carcinomas in aging mice
Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., Greenberg, R. A., Castrillon, D. H., Horner, J. W., Weiler, S. R., Carrasco, R. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112515399 · Cited by 317 · see citing works
Self-citationShort Telomeres Limit Tumor Progression In Vivo by Inducing Senescence
Feldser, D. M., & Greider, C. W. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.026 · Cited by 314 · see citing works
“Consistent with this role, p53 deficiency abrogates many of the cellular responses to short telomeres (Chin et al., 1999).”
InfluentialSelf-citationLeri, A., Franco, S., Zacheo, A., Barlucchi, L., Chimenti, S., Limana, F., Nadal‐Ginard, B., Kajstura, J., Anversa, P., & Blasco, M. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg013 · Cited by 313 · see citing works
Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation
Wong, K.-K., Chang, S., Weiler, S. R., Ganesan, S., Chaudhuri, J., Zhu, C., Artandi, S. E., Rudolph, K. L., Gottlieb, G. J., Chin, L., et al. (2000) · Nature Genetics · doi:10.1038/79232 · Cited by 309 · see citing works
“2 a , c ), along with evidence of telomere dysfunction (anaphase bridging) and elevated p53 expression (data not shown), consistent with previous observations that telomere dysfunction activates the p53 protei”
BackgroundSelf-citationMathon, N. F., & Lloyd, A. C. (2001) · Nature reviews. Cancer · doi:10.1038/35106045 · Cited by 306 · see citing works
Persistent Telomere Damage Induces Bypass of Mitosis and Tetraploidy
Davoli, T., Denchi, E. L., & de Lange, T. (2010) · Cell · doi:10.1016/j.cell.2010.01.031 · Cited by 298 · see citing works
- Authors
- Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
- Quest Diagnostics (United States) (US)
- Johns Hopkins University (US)
- Corresponding author
- DePinho, Ronald A
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 97
- Issue
- 4
- Pages
- 527-538
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2027779909
- Cited by
- 979
- References
- 44
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 18 · 2023: 21 · 2022: 15 · 2021: 22 · 2020: 15 · 2019: 26 · 2018: 24 · 2017: 23 · 2016: 32 · 2015: 34 · 2014: 23 · 2013: 40 · 2012: 51
- FWCI
- 36.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hd028317-05, 5r01hd034880-04, 5k08ar002104-04)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K08AR02104-01)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD34880, R01 HD28317)
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p53, telomere dysfunction, telomere shortening, telomerase deficiency, telomere crisis, carcinogenesis, genomic instability, tumor suppression, apoptosis, growth arrest, telomere length
- MeSH terms
- Animals, Male, Mice, Inbred C57BL, Neoplasms, Phenotype, Spermatozoa, Testis, Tumor Suppressor Protein p53, Telomere, Apoptosis, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review